Protein chip synthesis

The widespread use of protein chips has largely been limited by the need for large-scale protein purification
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
BALTIMORE—The widespread use of protein chips has largely been limited by the need for large-scale protein purification to generate a broad spectrum of proteins in a given cell type. Researchers at Johns Hopkins School of Medicine, however, have recently described their efforts to produce protein chips using on-chip gene expression and polypeptide immobilization.
Continue reading below...
Illustration of diverse healthcare professionals interacting with digital medical data and health records on virtual screens.
WebinarsAccelerating rare disease clinical trials
Explore how a rare kidney disease trial achieved faster patient enrollment with data-informed strategies and collaborative partnerships.
Read More
As they describe in Nature Biotechnology, the researchers relied on the fact that when a ribosome reaches duplex nucleic acid, it pauses just long enough for a puromycin molecule to enter the polypeptide synthesis site and become covalently bound to the nascent protein chain. Thus, in one scheme, the researchers attached mRNAs to silicon chips via streptavidin-biotin links. They then annealed a second short RNA primer to slow peptide synthesis and attached a puromycin-labeled oligo to the chip to capture the new peptide.
The researchers found that whether they were producing peptide tag sequences or full-length proteins, they could capture about 0.8 fmol protein per spot (or about 40,000 molecules). Furthermore, the captured peptides could be detected with anti-peptide antibodies and were capable of performing their normal biological functions.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Close-up of a researcher using a stylus to draw or interact with digital molecular structures on a blue scientific interface.
When molecules outgrow the limits of sketches and strings, researchers need a new way to describe and communicate them.
Portrait of Scott Weitze, Vice President of Research and Technical Standards at My Green Lab, beside text that reads “Tell us what you know: Bringing sustainability into scientific research,” with the My Green Lab logo.
Laboratories account for a surprising share of global emissions and plastic waste, making sustainability a priority for modern research.
3D illustration of RNA molecules on a gradient blue background.
With diverse emerging modalities and innovative delivery strategies, RNA therapeutics are tackling complex diseases and unmet medical needs.
Drug Discovery News September 2025 Issue
Latest IssueVolume 21 • Issue 3 • September 2025

September 2025

September 2025 Issue

Explore this issue